Proposed Data Collection Submitted for Public Comment and Recommendations, 10339-10340 [2023-03320]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 33 / Friday, February 17, 2023 / Notices
Centers for Disease Control and
Prevention
[60Day–23–0920; Docket No. CDC–2023–
0009]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Data Collection
Through Web Based Surveys for
Evaluating Act Against AIDS Social
Marketing Campaign Phases Targeting
Consumers. This project which includes
web surveys to test campaign
messaging.
SUMMARY:
CDC must receive written
comments on or before April 18, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2023–
0009 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
lotter on DSK11XQN23PROD with NOTICES1
DATES:
VerDate Sep<11>2014
17:13 Feb 16, 2023
Jkt 259001
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project
Data Collection Through Web Based
Surveys for Evaluating Act Against
AIDS Social Marketing Campaign
Phases Targeting Consumers (OMB
Control No. 0920–0920, Exp. 5/31/
2023)—Extension—National Center for
HIV/AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In response to the continued HIV
epidemic in our country, CDC launched
the Let’s Stop HIV Together campaign
(formerly known as Act Against AIDS),
a multifaceted communication
campaign to reduce HIV incidence in
the United States in 2009. CDC has
released the campaign in phases, with
some of the phases running
concurrently. Each phase of the
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
10339
campaign uses mass media and directto-consumer channels to deliver
messages. Some campaigns provide
basic education and increase awareness
of HIV/AIDS among the general public
whereas others emphasize HIV
prevention and testing among specific
subgroups or communities at greatest
risk of infection. CDC will also develop
new messages to address changes in
prevention science and subpopulations
affected by HIV. The proposed study
will assess the effectiveness of these
social marketing messages aimed at
increasing HIV/AIDS awareness,
increasing prevention behaviors, and
improving HIV testing rates among
consumers.
This Extension of an ongoing study
will allow for continued evaluation of
the effectiveness of Let’s Stop HIV
Together social marketing campaign
through surveys with consumers. A total
of 6,445 respondents were approved for
the previously renewed Generic ICR
(0920–0920) in 2022, and since the
approval date, 2,500 respondents were
surveyed under the GenIC,
‘‘Development of Messages for the Let’s
Stop HIV Together National Campaign’’.
The information collected from this
survey was used to evaluate the
acceptability and potential effectiveness
of proposed concepts, messages, and
taglines for a component of the Let’s
Stop HIV Together campaign focused on
HIV prevention that promotes proven,
effective prevention strategies, such as
pre-exposure prophylaxis (PrEP) and
treatment as prevention (TasP). We are
requesting a three-year Extension to
continue surveying target audiences.
Through this Extension, we plan to
reach the remaining approved 3,945
respondents. To obtain the remaining
respondents, we anticipate screening
approximately 26,336 individuals.
Depending on the target audience for
the campaign phase, the study screener
will vary. The study screener may
address one or more of the following
items: Race/ethnicity, sexual behavior,
sexual orientation, gender identity, HIV
testing history, HIV status, and injection
drug use. Each survey will have a core
set of items asked in all rounds, as well
as a module of questions relating to
specific Let’s Stop HIV Together phases
and activities.
Respondents will be recruited through
national opt-in email lists, the internet,
and external partnerships with
community-based and membership
organizations that work with or
represent individuals from targeted
populations (e.g., National Urban
League, the National Medical
Association). Respondents will selfadminister the survey at home on
E:\FR\FM\17FEN1.SGM
17FEN1
10340
Federal Register / Vol. 88, No. 33 / Friday, February 17, 2023 / Notices
personal computers. CDC requests OMB
approval for an estimated 2,849 annual
burden hours. There is no cost to the
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hr)
Total burden
(in hr)
Form name
Individuals (male and female) aged 18 years and older ...
Study Screener ...
Survey Module ....
26,336
3,945
1
1
2/60
30/60
877
1,972
Total ............................................................................
..............................
........................
........................
....................
2,849
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–03320 Filed 2–16–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–367a–e]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
April 18, 2023.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
VerDate Sep<11>2014
17:13 Feb 16, 2023
Jkt 259001
When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address:
CMS, Office of Strategic Operations
and Regulatory Affairs, Division of
Regulations Development, Attention:
Document Identifier/OMB Control
Number: ll, Room C4–26–05, 7500
Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–367a–e Medicaid Drug Rebate
Program Labeler Reporting Format
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicaid Drug
Rebate Program Labeler Reporting
Format; Use: Labelers transmit drug
product and pricing data to CMS within
30 days after the end of each calendar
month and quarter. CMS calculates the
unit rebate amount (URA) and the unit
rebate offset amount (UROA) for each
new drug application (NDC) and
distributes to all State Medicaid
agencies. States use the URA to invoice
the labeler for rebates and the UROA to
report onto CMS–64. The monthly data
is used to calculate Federal Upper Limit
(FUL) prices for applicable drugs and
for states that opt to use this data to
establish their pharmacy reimbursement
methodology. In this 2023 iteration, we
adding a new use of the reported data.
The new use would allow us to
calculate inflationary rebates under the
Inflation Reduction Act of 2022. The
change has no impact on our burden
estimates. We are not revising any of our
reporting forms. Form Number: CMS–
367a, b, c, d, and e (OMB control
number: 0938–0578); Frequency:
Monthly, quarterly, and on occasion;
Affected Public: Private sector (Business
or other for-profits); Number of
Respondents: 818; Total Annual
Responses: 15,742; Total Annual Hours:
E:\FR\FM\17FEN1.SGM
17FEN1
]]>Agencies
[Federal Register Volume 88, Number 33 (Friday, February 17, 2023)]
[Notices]
[Pages 10339-10340]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03320]
[[Page 10339]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-23-0920; Docket No. CDC-2023-0009]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Data Collection Through Web Based Surveys for Evaluating Act
Against AIDS Social Marketing Campaign Phases Targeting Consumers. This
project which includes web surveys to test campaign messaging.
DATES: CDC must receive written comments on or before April 18, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0009 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Data Collection Through Web Based Surveys for Evaluating Act
Against AIDS Social Marketing Campaign Phases Targeting Consumers (OMB
Control No. 0920-0920, Exp. 5/31/2023)--Extension--National Center for
HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In response to the continued HIV epidemic in our country, CDC
launched the Let's Stop HIV Together campaign (formerly known as Act
Against AIDS), a multifaceted communication campaign to reduce HIV
incidence in the United States in 2009. CDC has released the campaign
in phases, with some of the phases running concurrently. Each phase of
the campaign uses mass media and direct-to-consumer channels to deliver
messages. Some campaigns provide basic education and increase awareness
of HIV/AIDS among the general public whereas others emphasize HIV
prevention and testing among specific subgroups or communities at
greatest risk of infection. CDC will also develop new messages to
address changes in prevention science and subpopulations affected by
HIV. The proposed study will assess the effectiveness of these social
marketing messages aimed at increasing HIV/AIDS awareness, increasing
prevention behaviors, and improving HIV testing rates among consumers.
This Extension of an ongoing study will allow for continued
evaluation of the effectiveness of Let's Stop HIV Together social
marketing campaign through surveys with consumers. A total of 6,445
respondents were approved for the previously renewed Generic ICR (0920-
0920) in 2022, and since the approval date, 2,500 respondents were
surveyed under the GenIC, ``Development of Messages for the Let's Stop
HIV Together National Campaign''. The information collected from this
survey was used to evaluate the acceptability and potential
effectiveness of proposed concepts, messages, and taglines for a
component of the Let's Stop HIV Together campaign focused on HIV
prevention that promotes proven, effective prevention strategies, such
as pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP).
We are requesting a three-year Extension to continue surveying target
audiences.
Through this Extension, we plan to reach the remaining approved
3,945 respondents. To obtain the remaining respondents, we anticipate
screening approximately 26,336 individuals. Depending on the target
audience for the campaign phase, the study screener will vary. The
study screener may address one or more of the following items: Race/
ethnicity, sexual behavior, sexual orientation, gender identity, HIV
testing history, HIV status, and injection drug use. Each survey will
have a core set of items asked in all rounds, as well as a module of
questions relating to specific Let's Stop HIV Together phases and
activities.
Respondents will be recruited through national opt-in email lists,
the internet, and external partnerships with community-based and
membership organizations that work with or represent individuals from
targeted populations (e.g., National Urban League, the National Medical
Association). Respondents will self-administer the survey at home on
[[Page 10340]]
personal computers. CDC requests OMB approval for an estimated 2,849
annual burden hours. There is no cost to the respondents other than
their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in hr)
respondent (in hr)
----------------------------------------------------------------------------------------------------------------
Individuals (male and female) Study Screener.... 26,336 1 2/60 877
aged 18 years and older.
Survey Module..... 3,945 1 30/60 1,972
------------------------------------------------------------
Total...................... .................. .............. .............. ........... 2,849
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-03320 Filed 2-16-23; 8:45 am]
BILLING CODE 4163-18-P
